These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13255446)

  • 1. The mechanism of action of antileukemic drugs.
    BURCHENAL JH
    Rev Hematol; 1955; 10(2):485-6. PubMed ID: 13255446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mode of action of antileukemic therapeutic agents].
    MALLARME J
    Rev Hematol; 1955; 10(2):473-5. PubMed ID: 13255444
    [No Abstract]   [Full Text] [Related]  

  • 3. [One of the aspects of the leukopenizing action of antileukemic chemotherapy studied by means of leukocyte resistance].
    STORTI E
    Rev Hematol; 1955; 10(2):492-506. PubMed ID: 13255448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress of antileukemic chemotherapy].
    BERNARD J
    Pathol Biol; 1960 Feb; 8():337-42. PubMed ID: 13799651
    [No Abstract]   [Full Text] [Related]  

  • 5. Some thoughts on the rationale of antileukemic therapy.
    Bernard J; Bessis M
    Blood Cells; 1982; 8(3):477-82. PubMed ID: 6760932
    [No Abstract]   [Full Text] [Related]  

  • 6. [A synthetic antileukemic agent, 6-mercaptopurine].
    MARINHO HM
    Med Cir Farm; 1955 Aug; (232):364-8. PubMed ID: 13279419
    [No Abstract]   [Full Text] [Related]  

  • 7. [The HIV virus used as antileukemic vector].
    Nau JY
    Rev Med Suisse; 2013 Jan; 9(368):86-7. PubMed ID: 23367714
    [No Abstract]   [Full Text] [Related]  

  • 8. Remissions after exchange transfusions in acute leukemia. On the possible antileukemic properties of normal blood. Historical notes and recent reflections.
    Bessis M; Bernard J
    Blood Cells; 1983; 9(1):75-82. PubMed ID: 6344936
    [No Abstract]   [Full Text] [Related]  

  • 9. Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.
    Weiden PL; Flournoy N; Sanders JE; Sullivan KM; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 1):248-51. PubMed ID: 7022833
    [No Abstract]   [Full Text] [Related]  

  • 10. CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease.
    Fevery S; Billiau AD; Sprangers B; Rutgeerts O; Lenaerts C; Goebels J; Landuyt W; Kasran A; Boon L; Sagaert X; De Wolf-Peeters C; Waer M; Vandenberghe P
    Leukemia; 2007 Jul; 21(7):1451-9. PubMed ID: 17508005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antileukemic potential of natural killer cells.
    Torelli GF; Peragine N; Mariglia P; Foà R
    Immunotherapy; 2016; 8(4):425-34. PubMed ID: 26973124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status of the multidisciplinary treatment of acute leukemia].
    Masaoka T
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1019-23. PubMed ID: 3903254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R
    N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.
    Weiden PL; Sullivan KM; Flournoy N; Storb R; Thomas ED;
    N Engl J Med; 1981 Jun; 304(25):1529-33. PubMed ID: 7015133
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of the graft-versus-leukemia reaction.
    Barrett AJ
    Stem Cells; 1997; 15(4):248-58. PubMed ID: 9253108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?
    Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø
    Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of antileukemic agents in leukemia chemotherapy].
    Nakamura T
    Rinsho Ketsueki; 1996 May; 37(5):380-91. PubMed ID: 8691581
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell therapy of leukemia.
    Riddell SR; Murata M; Bryant S; Warren EH
    Cancer Control; 2002; 9(2):114-22. PubMed ID: 11965232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidisciplinary treatment of leukemia].
    Masaoka T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):987-92. PubMed ID: 2658820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.